EPA Denies Denka's Chloroprene IRIS Correction Request Using New Tool

摘要

Citing a new analytical approach recommended by the National Academy of Sciences (NAS), EPA has denied a chemical company's request to withdraw or correct its assessment of the health risks of the chemical chloroprene -which the company charges is driving an unusual and costly enforcement action at its Louisiana facility. "The EPA, after careful review of the [request for correction (RFC)] submitted by [Denka Performance Elastomers (DPE)], has concluded that the underlying information and conclusions presented in the Toxicological Review of Chloroprene ... are consistent with the EPA's Information Quality Guidelines," EPA's top staff research official concludes in a Jan. 24 response to the company. Relevant documents are available on InsideEPA.com. (Doc. ID: 209063) The agency's denial of the RFC appears to undercut efforts by congressional Republicans who had cited the Integrated Risk Information System' (IRIS) chloroprene assessment and the resulting enforcement action against Denka as a poster child for why the program needed to be eliminated or overhauled.